LigaChem Biosciences Inc. (KOSDAQ:141080)
107,100
+1,100 (1.04%)
Jun 19, 2025, 3:30 PM KST
LigaChem Biosciences Revenue
LigaChem Biosciences had revenue of 51.58B KRW in the quarter ending March 31, 2025, with 66.07% growth. This brings the company's revenue in the last twelve months to 146.42B, up 154.45% year-over-year. In the year 2024, LigaChem Biosciences had annual revenue of 125.90B with 268.71% growth.
Revenue (ttm)
146.42B
Revenue Growth
+154.45%
P/S Ratio
26.52
Revenue / Employee
861.28M
Employees
170
Market Cap
3,882.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 125.90B | 91.75B | 268.71% |
Dec 31, 2023 | 34.15B | 733.60M | 2.20% |
Dec 31, 2022 | 33.41B | 1.26B | 3.90% |
Dec 31, 2021 | 32.16B | -25.34B | -44.07% |
Dec 31, 2019 | 57.50B | 32.26B | 127.81% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 4.30B |
PharmaResearch | 392.31B |